免疫检查点活性蛋白及相关产品
CTLA-4,PD-1,IDO1,B7-H4,LAG-3,Tim-3
◆活性免疫检测点蛋白
B7-H4 (human):Fc (human) (rec.) | |
B7-H4 (mouse):Fc (mouse) (rec.) | |
CTLA-4 (human):Fc (human) (rec.) | |
CTLA-4 (human):Fc (human) (rec.) (non-lytic) | |
CTLA-4 (human):Fc (mouse) (rec.) | |
CTLA-4 (mouse):Fc (mouse) (rec.) | |
CTLA-4 (mouse):Fc (mouse) (rec.) (non-lytic) | |
PD-1 (human):Fc (human) (rec.) | |
PD-1 (human):Fc (human) (rec.) (non-lytic) | |
PD-1 (mouse):Fc (mouse) (rec.) | |
PD-L1/B7-H1 (human):Fc (human) (rec.) | |
PD-L1/B7-H1 (human):Fc (human) (rec.) (non-lytic) | |
PD-L1/B7-H1 (mouse):Fc (mouse) (rec.) | |
PD-L1/B7-H1 (mouse):Fc (mouse) (rec.) (non-lytic) | |
PD-L2 (human):Fc (human) (rec.) | |
PD-L2 (human):Fc (human) (rec.) (non-lytic) | |
PD-L2 (mouse):Fc (mouse) (rec.) |
◆IDO1酶&主要抑制剂
IDO1 (human) Enzyme+Inhibitor Set | |
IDO1 (human) (rec.) (His) (highly active) | |
MMG-0358 (Potent Triazole IDO1 Inhibitor) | AG-CR1-3630 |
IC50值,mIDO1细胞检测是2 nM,hIDO1细胞检测是80 nM,hIDO1(pH 6.5)酶活检测是330 nM,hIDO1(pH7.4)的酶活检测是71 nM。体内有活性。
参考文献
Rational design of 4-aryl-1,2,3-triazoles for indoleamine 2,3-dioxygenase 1 inhibition: U.F. Roehrig, et al.; J. Med. Chem. , 55, 5270 (2012)
◆肿瘤免疫治疗的LAG-3
功能性封闭抗体 | |
LAG-3 (human), mAb (blocking) (17B4) | |
LAG-3 (human), mAb (blocking) (17B4) (preservative free) | |
LAG-3, mAb (blocking) (11E3) | |
LAG-3, mAb (blocking) (11E3) (preservative free) | |
生物活性蛋白 | |
LAG-3 (human):Fc (human) (rec.) | |
LAG-3 (mouse):Fc (mouse) (rec.) |
◆T-细胞免疫球蛋白和粘蛋白结构域
Tim-3 (human):Fc (human) (rec.) | |
Tim-3 (mouse):Fc (mouse) (rec.) |
◆CD1d配体抗肿瘤佐剂
α-Galactosylceramide | Potent NKT Cell stimulator 强有效NKT 激活剂 |
在人类和小鼠NKT细胞里MHC-I蛋白和CD1d分子脂质结合的特异性配体。
参考文献
LIT: Combination of the toll like receptor agonist and α-Galactosylceramide as an efficient adjuvant for cancer vaccine: F. Gableh, et al.; J. Biomed. Sci., 23, 16 (2016)
※ 本页面产品仅供研究用,研究以外不可使用。
产品编号 | 产品名称 | 产品规格 | 产品等级 | 备注 |
CHI-HF-210B7H4-C100 | B7-H4 (human):Fc (human) (rec.) B7-H4 (人):Fc (人) (重组) |
100 µg | - | - |
CHI-MF-110B7H4-C100 | B7-H4 (mouse):Fc (mouse) (rec.) B7-H4 (小鼠):Fc (小鼠) (重组) |
100 µg | - | - |
CHI-HF-210A4-C100 | CD152 [CTLA-4] (human):Fc (human) (rec.) CD152 [CTLA-4] (人):Fc (人) (重组) |
100 µg | - | - |
CHI-HF-210A4-C500 | CD152 [CTLA-4] (human):Fc (human) (rec.) CD152 [CTLA-4] (人):Fc (人) (重组) |
500 µg | - | - |
CHI-HF-220A4-C100 | CD152 [CTLA-4] (human):Fc (human) (rec.) (non-lytic) CD152 [CTLA-4] (人):Fc (人) (重组) (非分解) |
100 µg | - | - |
CHI-HF-220A4-C500 | CD152 [CTLA-4] (human):Fc (human) (rec.) (non-lytic) CD152 [CTLA-4] (人):Fc (人) (重组) (非分解) |
500 µg | - | - |
CHI-HF-211A4-C100 | CD152 [CTLA-4] (human):Fc (mouse) (rec.) CD152 [CTLA-4] (人):Fc (小鼠) (重组) |
100 µg | - | - |
CHI-MF-110A4-C100 | CD152 [CTLA-4] (mouse):Fc (mouse) (rec.) CD152 [CTLA-4] (小鼠):Fc (小鼠) (重组) |
100 µg | - | - |
CHI-MF-110A4-C500 | CD152 [CTLA-4] (mouse):Fc (mouse) (rec.) CD152 [CTLA-4] (小鼠):Fc (小鼠) (重组) |
500 µg | - | - |
CHI-MF-120A4-C100 | CD152 [CTLA-4] (mouse):Fc (mouse) (rec.) (non-lytic) CD152 [CTLA-4] (小鼠):Fc (小鼠) (重组) (非分解 |
100 µg | - | - |
CHI-MF-120A4-C500 | CD152 [CTLA-4] (mouse):Fc (mouse) (rec.) (non-lytic) CD152 [CTLA-4] (小鼠):Fc (小鼠) (重组) (非分解 |
500 µg | - | - |
CHI-HF-210PD1-C100 | CD279 [PD-1] (human):Fc (human) (rec.) CD279 [PD-1] (人):Fc (人) (重组) |
100 µg | - | - |
CHI-HF-220PD1-C200 | CD279 [PD-1] (human):Fc (human) (rec.) (non-lytic) CD279 [PD-1] (人):Fc (人) (重组) (非分解) |
200 µg | - | - |
CHI-MF-110PD1-C100 | CD279 [PD-1] (mouse):Fc (mouse) (rec.) CD279 [PD-1] (小鼠):Fc (小鼠) (重组) |
100 µg | - | - |
CHI-HF-210PDL1-C100 | CD274 [B7-H1/PD-L1] (human):Fc (human) (rec.) CD274 [B7-H1/PD-L1] (人):Fc (人) (重组) |
100 µg | - | - |
CHI-HF-220PD1-C200 | CD279 [PD-1] (human):Fc (human) (rec.) (non-lytic) CD279 [PD-1] (人):Fc (人) (重组) (非分解) |
200 µg | - | - |
CHI-MF-110PD1-C100 | CD279 [PD-1] (mouse):Fc (mouse) (rec.) CD279 [PD-1] (小鼠):Fc (小鼠) (重组) |
100 µg | - | - |
CHI-HF-210PDL1-C100 | CD274 [B7-H1/PD-L1] (human):Fc (human) (rec.) CD274 [B7-H1/PD-L1] (人):Fc (人) (重组) |
100 µg | - | - |
CHI-HF-220PDL1-C100 | CD274 [B7-H1/PD-L1] (human):Fc (human) (rec.) (non-lytic) CD274 [B7-H1/PD-L1] (人):Fc (人) (重组) (非分解) |
100 µg | - | - |
CHI-MF-110PDL1-C100 | CD274 [B7-H1/PD-L1] (mouse):Fc (mouse) (rec.) CD274 [B7-H1/PD-L1] (小鼠):Fc (小鼠) (重组) |
100 µg | - | - |
CHI-MF-120PDL1-C100 | CD274 [B7-H1/PD-L1] (mouse):Fc (mouse) (rec.) (non-lytic) CD274 [B7-H1/PD-L1] (小鼠):Fc (小鼠) (重组) (非分解) |
100 µg | - | - |
CHI-HF-210PDL2-C100 | CD273 [PD-L2] (human):Fc (human) (rec.) CD273 [PD-L2] (人):Fc (人) (重组) |
100 µg | - | - |
CHI-HF-220PDL2-C100 | CD273 [PD-L2] (human):Fc (human) (rec.) (non-lytic) CD273 [PD-L2] (人):Fc (人) (重组) (非分解) |
100 µg | - | - |
CHI-MF-110PDL2-C100 | CD273 [PD-L2] (mouse):Fc (mouse) (rec.) CD273 [PD-L2] (小鼠):Fc (小鼠) (重组) |
100 µg | - | - |
产品编号 | 产品名称 | 产品规格 | 产品等级 | 备注 |
AG-44B-0006-KI01 | IDO1 (human) Enzyme+Inhibitor Set IDO1(人)酶+抑制剂 套装 | 1 Set | - | - |
AG-40B-0161-C050 | IDO1 (human) (rec.) (His) (highly active) 高活性重组人IDO1蛋白(His) | 50 µg | - | - |
AG-CR1-3630-M001 | MMG-0358 | 1 mg | - | - |
AG-CR1-3630-M005 | MMG-0358 | 5 mg | - | - |
产品编号 | 产品名称 | 产品规格 | 产品等级 | 备注 |
AG-20B-0012-C100 | anti-LAG-3 (human), mAb (blocking) (17B4) 抗人LAG3单抗(17B4)(封闭作用) |
100 µg | - | - |
AG-20B-0012B-C100 | anti-LAG-3 (human), mAb (17B4) (Biotin) 抗人LAG3单抗(17B4)(生物素标记) |
100 µg | - | - |
AG-20B-0012F-C100 | anti-LAG-3 (human), mAb (17B4) (FITC) 抗人LAG3单抗(17B4)(FITC标记) |
100 µg | - | - |
AG-20B-0012TD-T100 | anti-LAG-3 (human), mAb (17B4) (ATTO 488) 抗人LAG3单抗(17B4)(ATTO 488) |
100 tests | - | - |
AG-20B-0012TM-T100 | anti-LAG-3 (human), mAb (17B4) (ATTO 590) 抗人LAG3单抗(17B4)(ATTO 590) |
100 tests | - | - |
AG-20B-0012TS-T100 | anti-LAG-3 (human), mAb (17B4) (ATTO 647N) 抗人LAG3单抗(17B4)(ATTO 647N) |
100 tests | - | - |
AG-20B-0012PF-C100 | anti-LAG-3 (human), mAb (blocking) (17B4) (preservative free) 抗人LAG3单抗(17B4)(封闭作用)(不含防腐剂) |
100 µg | - | - |
AG-20B-0012PF-C500 | anti-LAG-3 (human), mAb (17B4) (blocking) (preservative free) | 500 µg | - | - |
AG-20B-0012PF-C100 | anti-LAG-3 (human), mAb (blocking) (17B4) (preservative free) 抗人LAG3单抗(17B4)(封闭作用)(不含防腐剂) |
100 µg | - | - |
AG-20B-0012PF-C500 | anti-LAG-3 (human), mAb (17B4) (blocking) (preservative free) | 500 µg | - | - |
AG-20B-0011-C100 | anti-LAG-3, mAb (blocking) (11E3) LAG-3单抗(封闭作用)(11E3) |
100 µg | - | - |
AG-20B-0011PF-C100 | anti-LAG-3, mAb (blocking) (11E3) (preservative free) LAG-3单抗(封闭作用)(11E3)(不含防腐剂) |
100 µg | - | - |
AG-20B-0011PF-C500 | anti-LAG-3, mAb (blocking) (11E3) (preservative free) | 500 µg | - | - |
AG-20B-0011PF-C100 | anti-LAG-3, mAb (blocking) (11E3) (preservative free) LAG-3单抗(封闭作用)(11E3)(不含防腐剂) |
100 µg | - | - |
AG-20B-0011PF-C500 | anti-LAG-3, mAb (blocking) (11E3) (preservative free) | 500 µg | - | - |
AG-40B-0031-C050 | LAG-3 (human):Fc (human) (rec.) 重组型LAG-3(人):Fc(人) |
50 µg | - | - |
AG-40B-0039-C050 | LAG-3 (mouse):Fc (mouse) (rec.) 重组型LAG-3(小鼠):Fc(小鼠) |
50 µg | - | - |
产品编号 | 产品名称 | 产品规格 | 产品等级 | 备注 |
CHI-HF-210T3-C100 | Tim-3 (human):Fc (human) (rec.) Tim-3 (人):Fc (人) (重组) |
100 µg | - | - |
CHI-MF-110T3-C100 | Tim-3 (mouse):Fc (mouse) (rec.) | 100 µg | - | - |
产品编号 | 产品名称 | 产品规格 | 产品等级 | 备注 |
AG-CN2-0013-C250 | alpha-Galactosylceramide α-半乳糖神经酰胺,NK细胞激活剂 |
250 µg | - | - |
AG-CN2-0013-M001 | alpha-Galactosylceramide α-半乳糖神经酰胺,NK细胞激活剂 |
1 mg | - | - |
AG-CN2-0013-M005 | alpha-Galactosylceramide | 5 mg | - | - |
免责声明 |
1. 本公司密切关注本网站发布的内容,但不保证发布内容的准确性、完整性、可靠性和最新性等。 2. 本公司不保证使用本网站期间不会出现故障或计算机病毒污染的风险。 3. 无论何种原因,使用本网站时给用户或第三方造成的任何不利或损害,本公司概不负责。此外,对于用户与其他用户或第三方之间因本网站发生的任何交易、通讯 3. 或纠纷,本公司概不负责。 4. 本网站可提供的所有产品和服务均不得用于人体或动物的临床诊断或治疗,仅可用于科研等非医疗目的。如任何用户将本网站提供的产品和服务用于临床诊断或治 4. 疗,以及其他特定的用途或行为,本公司概不保证其安全性和有效性,并且不负任何相关的法律责任。 |